|
HELZ expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.414650E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.323680E-02 |
| Normal-vs-Stage2 |
2.684200E-01 |
| Normal-vs-Stage3 |
9.643400E-01 |
| Normal-vs-Stage4 |
3.721000E-01 |
| Stage1-vs-Stage2 |
6.885600E-01 |
| Stage1-vs-Stage3 |
1.810220E-02 |
| Stage1-vs-Stage4 |
1.464380E-03 |
| Stage2-vs-Stage3 |
2.863600E-01 |
| Stage2-vs-Stage4 |
9.682300E-02 |
| Stage3-vs-Stage4 |
3.685800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.068800E-01 |
| Normal-vs-AfricanAmerican |
2.316600E-01 |
| Normal-vs-Asian |
1.482110E-02 |
| Caucasian-vs-AfricanAmerican |
2.294000E-02 |
| Caucasian-vs-Asian |
1.144280E-03 |
| AfricanAmerican-vs-Asian |
9.85369999999541E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.382600E-01 |
| Normal-vs-Female |
5.144400E-02 |
| Male-vs-Female |
2.162400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.133200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.637900E-02 |
| Normal-vs-Age(61-80Yrs) |
4.896400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.293800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.071600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.217600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.298200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.826400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.256500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.421400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.245800E-04 |
| Normal-vs-Grade 2 |
1.092400E-02 |
| Normal-vs-Grade 3 |
6.495000E-01 |
| Normal-vs-Grade 4 |
2.988000E-01 |
| Grade 1-vs-Grade 2 |
1.032170E-01 |
| Grade 1-vs-Grade 3 |
5.417400E-03 |
| Grade 1-vs-Grade 4 |
4.593700E-04 |
| Grade 2-vs-Grade 3 |
2.005500E-02 |
| Grade 2-vs-Grade 4 |
1.021820E-03 |
| Grade 3-vs-Grade 4 |
1.517410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.552900E-04 |
| Normal-vs-ccB subtype |
5.414200E-01 |
| ccA subtype-vs-ccB subtype |
3.244100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.791700E-02 |
| Normal-vs-N1 |
6.309400E-01 |
| N0-vs-N1 |
8.911000E-01 |
|
|
